• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.17%

    Regulus Therapeutics Inc. (RGLS)

    -NasdaqGM
    1.10 Up 0.05(4.76%) Feb 24, 4:00PM EST
    |After Hours : 1.10 0.00 (0.00%) Feb 24, 5:16PM EST
    Prev Close:1.05
    Open:1.05
    Bid:1.00 x 3000
    Ask:1.35 x 600
    1y Target Est:7.00
    Beta:2.55369
    Next Earnings Date: 2-Mar-17RGLS Earnings announcement
    Day's Range:0.94 - 1.10
    52wk Range:0.94 - 8.90
    Volume:2,078,984
    Avg Vol (3m):830,392
    Market Cap:58.22M
    P/E (ttm):N/A
    EPS (ttm):-1.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RGLS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.49
    Quarterly EPS Est (Dec-16) :-0.37
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.02

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target RNAs to treat a range of diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback